DCGO · XBRL financial data

DocGo financial statements, every fiscal year

The same tables from 7 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (DCGO's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue	94,091	318,719	440,516	624,289	616,555	322,196
Cost of revenue	—	451,696	523,948	—	—	—
Research and development	1,190	3,320	5,385	10,859	11,589	13,563
General and administrative	34,913	74,893	103,403	137,153	138,759	133,450
Total operating expenses	108,848	303,361	418,684	609,234	587,866	500,230
Other operating income (expense)	126	4,438	950	1,238	(940)	(9,465)
Operating income (loss)	(14,758)	15,357	21,832	15,055	28,689	(178,034)
Interest expense	16	61	118	—	—	—
Other income (expense)	300	(40)	(987)	(687)	229	(532)
Income tax expense (benefit)	167	616	(7,961)	6,356	14,388	8,868
Net income (loss)	(14,799)	19,179	34,584	6,858	19,992	(182,400)
Earnings per share, basic USD per share	(0.25)	0.30	0.34	0.07	0.20	(1.84)
Earnings per share, diluted USD per share	(0.25)	0.25	0.34	0.06	0.18	(1.84)
Weighted average shares, basic thousands of shares	58,370	80,294	101,228	103,511	102,395	99,069
Weighted average shares, diluted thousands of shares	58,370	94,864	102,976	105,618	109,423	99,069

Fiscal years (DCGO's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	879	175,537	157,335	59,286	89,242	51,019
Prepaid and other current assets	169	2,112	6,270	17,500	4,345	—
Total current assets	1,048	256,032	271,081	338,870	304,486	152,399
Property and equipment, net	9,106	12,734	21,258	16,835	14,881	14,558
Right-of-use asset	4,997	4,196	9,074	9,581	11,959	11,521
Goodwill	6,611	8,687	38,900	47,540	47,433	0
Total assets	116,068	309,603	393,278	490,452	455,621	217,103
Accounts payable	12	15,834	21,583	19,827	28,356	11,111
Accrued liabilities	14,254	35,111	31,573	91,341	49,897	42,789
Current portion of long-term debt	—	600	665	28	13	52
Total current liabilities	160	57,876	100,158	170,119	121,807	67,490
Long-term debt	—	—	—	42	5	184
Lease liability, non-current	3,638	2,981	7,041	7,224	8,599	7,564
Total liabilities	13,226	82,546	114,350	185,281	140,442	91,232
Accumulated deficit	(12,158)	(63,557)	(28,972)	(21,394)	(1,402)	(183,802)
Total stockholders' equity	(12,158)	219,582	273,231	300,795	320,917	144,012
Total liabilities and equity	116,068	309,603	393,278	490,452	455,621	217,103
Common shares outstanding (cover page) thousands of shares	76,489	100,174	102,508	104,171	101,983	98,750

Fiscal years (DCGO's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	(14,799)	19,179	34,584	6,858	19,992	(182,400)
Stock-based compensation	—	1,376	8,055	20,969	13,634	17,442
Depreciation and amortization	—	2,312	10,566	4,830	15,885	15,662
Net cash from operating activities	(10,655)	(1,947)	28,870	(64,222)	70,337	34,452
Purchases of property and equipment	4,362	4,808	3,198	7,585	3,834	4,544
Net cash from investing activities	(6,040)	(8,589)	(38,448)	(29,882)	(10,872)	(39,083)
Proceeds from issuing common stock	—	178,102	0	0	—	—
Share repurchases	—	0	3,732	0	13,756	10,829
Net cash from financing activities	(812)	155,206	(6,180)	1,119	(24,155)	(50,817)
Net change in cash	(17,310)	144,648	(14,997)	(91,891)	35,119	(54,853)

SIC 8000 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 8000 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
DocGo	25,233	73,425	(9,242)*	98.9M	2.7 quarters	Q2 FY26 10-QJun 30, 2026
InnovAge Holding	119,253	264,757	28,742	136.5M	—	Q1 FY27 10-QSep 30, 2026
Strata Critical Medical	35,136	74,081	9,458*	89.3M	—	Q3 FY26 10-QSep 30, 2026
Talkspace	39,159	61,672	11,385*	165.8M	—	Q2 FY26 10-QJun 30, 2026
U S Physical Therapy	24,887	214,059	34,370*	14.9M	—	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.